AstraZeneca Bolsters Immuno-Oncology Portfolio via Deals with Celgene and Innate Pharma
By Heather Cartwright & Smita Mishra
Pharma Deals Review: Vol 2015 Issue 5 (Table of Contents)
Published: 15 May-2015
DOI: 10.3833/pdr.v2015.i5.2102 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
With a pair of deals worth more than US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS